Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2018-02-15 Investor Presentation
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Resultat for 4 kvartal og foreløpig resultat for 2017
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Fourth Quarter 2017" and dated February 15th, 2018. It contains detailed financial statements for Q4 2017 and the full year 2017, including Profit and Loss statements, Balance Sheets, and segment revenue breakdowns. This comprehensive financial reporting for a specific fiscal period (quarterly) strongly indicates an Interim/Quarterly Report. It is too detailed to be just an Earnings Release (ER) and is not the full annual report (10-K). Therefore, the classification is Interim / Quarterly Report (IR).
2018-02-15 Norwegian
Results for the 4th quarter and preliminary results for 2017
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Fourth Quarter 2017" and dated February 15th, 2018. It contains detailed financial statements for Q4 2017 and the full year 2017, including Profit and Loss statements, Balance Sheets, and segment revenue breakdowns. This comprehensive financial reporting for a specific fiscal period (quarterly) strongly indicates an Interim/Quarterly Report. It is too detailed to be just an Earnings Release (ER) and is not the full annual report (10-K). Therefore, the classification is Interim / Quarterly Report (IR).
2018-02-15 English
Resultat for 4 kvartal og foreløpig resultat for 2017
Earnings Release Classification · 100% confidence The document text provides key financial highlights for the 4th quarter and the full year 2017, including revenue (Omsetning), operating profit (EBIT), growth percentages, and a proposed dividend (utbytte). This structure—presenting summarized, period-specific financial performance metrics immediately following the period's end—is characteristic of an Earnings Release (ER). It is too brief and summary-focused to be a comprehensive Interim Report (IR) or Annual Report (10-K). The mention of the proposed dividend (NOK 2.00 per share) is a common component of an earnings announcement. Q4 2017
2018-02-15 Norwegian
Results for the 4th quarter and preliminary results for 2017
Earnings Release Classification · 100% confidence The document provides key financial highlights, including sales figures, EBIT, growth percentages, and a proposed dividend, specifically for the '4th quarter and preliminary results for 2017'. This structure—presenting summarized, period-specific financial performance data immediately following the period close—is characteristic of an Earnings Release (ER), which typically contains the key highlights before the full, detailed report (like a 10-K or IR) is issued. The document is short and focuses on summary metrics, not a comprehensive narrative or regulatory filing. Q4 2017
2018-02-15 English
Presentasjon av resultater for 4. kvartal og foreløpig årsregnskap 2017 for Medistim ASA
Report Publication Announcement Classification · 95% confidence The document text is very short (524 characters) and announces an upcoming presentation regarding the results for the 4th quarter and preliminary annual accounts for 2017 for Medistim ASA. It explicitly states that the presentation will take place 'i forbindelse med framleggelse av 4. kvartal og foreløpig årsregnskap 2017' (in connection with the presentation of Q4 and preliminary annual accounts 2017). This structure—announcing an event where results will be presented—is characteristic of a Report Publication Announcement (RPA) or potentially an Investor Presentation (IP) if the content were the slides themselves. Given the brevity and the focus on announcing the presentation event itself, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it is announcing the availability/presentation of the results rather than being the full report (10-K or IR).
2018-02-14 Norwegian
Presentation of fourth quarter results and preliminary results for 2017 for Medistim ASA
Investor Presentation Classification · 95% confidence The document text explicitly states it is a 'Presentation of fourth quarter results and preliminary results for 2017' and invites attendees to a presentation event. This strongly suggests the document is the material used for an investor presentation or a call related to earnings/results, rather than the full formal report (like 10-K or IR). Since it is a presentation of results, the most fitting category is Investor Presentation (IP). Although it relates to Q4 results, it is presented as an invitation/material for a presentation event, not the formal Earnings Release (ER) or the comprehensive Interim Report (IR). Given the context of a presentation being held, IP is the best fit.
2018-02-14 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.